Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15674209rdf:typepubmed:Citationlld:pubmed
pubmed-article:15674209lifeskim:mentionsumls-concept:C0009402lld:lifeskim
pubmed-article:15674209lifeskim:mentionsumls-concept:C0290149lld:lifeskim
pubmed-article:15674209lifeskim:mentionsumls-concept:C0534628lld:lifeskim
pubmed-article:15674209lifeskim:mentionsumls-concept:C0494165lld:lifeskim
pubmed-article:15674209lifeskim:mentionsumls-concept:C0311400lld:lifeskim
pubmed-article:15674209lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:15674209lifeskim:mentionsumls-concept:C0728940lld:lifeskim
pubmed-article:15674209lifeskim:mentionsumls-concept:C0205217lld:lifeskim
pubmed-article:15674209lifeskim:mentionsumls-concept:C0175630lld:lifeskim
pubmed-article:15674209lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:15674209lifeskim:mentionsumls-concept:C0547047lld:lifeskim
pubmed-article:15674209lifeskim:mentionsumls-concept:C0205225lld:lifeskim
pubmed-article:15674209pubmed:issue2lld:pubmed
pubmed-article:15674209pubmed:dateCreated2005-1-27lld:pubmed
pubmed-article:15674209pubmed:abstractTextRemoval of a primary colorectal tumor resulted in an increase in metabolic activity in its liver metastasis. Concomitantly, levels of angiostatin and endostatin in urine and plasma, respectively, dropped. This finding indicates that the primary tumor suppressed angiogenesis in its distant metastasis, and that removal of the primary lesion caused a flare-up in vessel neoformation and, thus, enhanced metabolic activity in its liver metastasis.lld:pubmed
pubmed-article:15674209pubmed:languageenglld:pubmed
pubmed-article:15674209pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15674209pubmed:citationSubsetAIMlld:pubmed
pubmed-article:15674209pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15674209pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15674209pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15674209pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15674209pubmed:statusMEDLINElld:pubmed
pubmed-article:15674209pubmed:monthFeblld:pubmed
pubmed-article:15674209pubmed:issn0039-6060lld:pubmed
pubmed-article:15674209pubmed:authorpubmed-author:WestphalJohan...lld:pubmed
pubmed-article:15674209pubmed:authorpubmed-author:RuiterDirk...lld:pubmed
pubmed-article:15674209pubmed:authorpubmed-author:de...lld:pubmed
pubmed-article:15674209pubmed:authorpubmed-author:OyenWim J GWJlld:pubmed
pubmed-article:15674209pubmed:authorpubmed-author:WobbesTheoTlld:pubmed
pubmed-article:15674209pubmed:authorpubmed-author:RuersTheo JTJlld:pubmed
pubmed-article:15674209pubmed:authorpubmed-author:PeetersCharlo...lld:pubmed
pubmed-article:15674209pubmed:authorpubmed-author:de...lld:pubmed
pubmed-article:15674209pubmed:issnTypePrintlld:pubmed
pubmed-article:15674209pubmed:volume137lld:pubmed
pubmed-article:15674209pubmed:ownerNLMlld:pubmed
pubmed-article:15674209pubmed:authorsCompleteYlld:pubmed
pubmed-article:15674209pubmed:pagination246-9lld:pubmed
pubmed-article:15674209pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15674209pubmed:meshHeadingpubmed-meshheading:15674209...lld:pubmed
pubmed-article:15674209pubmed:meshHeadingpubmed-meshheading:15674209...lld:pubmed
pubmed-article:15674209pubmed:meshHeadingpubmed-meshheading:15674209...lld:pubmed
pubmed-article:15674209pubmed:meshHeadingpubmed-meshheading:15674209...lld:pubmed
pubmed-article:15674209pubmed:meshHeadingpubmed-meshheading:15674209...lld:pubmed
pubmed-article:15674209pubmed:meshHeadingpubmed-meshheading:15674209...lld:pubmed
pubmed-article:15674209pubmed:meshHeadingpubmed-meshheading:15674209...lld:pubmed
pubmed-article:15674209pubmed:meshHeadingpubmed-meshheading:15674209...lld:pubmed
pubmed-article:15674209pubmed:meshHeadingpubmed-meshheading:15674209...lld:pubmed
pubmed-article:15674209pubmed:year2005lld:pubmed
pubmed-article:15674209pubmed:articleTitleDecrease in circulating anti-angiogenic factors (angiostatin and endostatin) after surgical removal of primary colorectal carcinoma coincides with increased metabolic activity of liver metastases.lld:pubmed
pubmed-article:15674209pubmed:affiliationDepartment of Pathology 437, University Medical Center, PO Box 9101, Nijmegen 6500 HB, The Netherlands. c.peeters@pathol.umcn.nllld:pubmed
pubmed-article:15674209pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15674209pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:15674209pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15674209lld:pubmed